Xcell Biosciences, a provider of novel and disruptive systems for cell therapy development and production which combines rapid primary cell expansion and fine control of cell population mix and phenotype across a range of therapeutically important human cell types, has launched a Technology Access Program (TAP) and the first TAP partner, ImmunXperts in Gosselies, Belgium.   “Xcell Biosciences created the Technology Access Program (TAP) to accelerate the discovery of novel applications usin...